NCT06355856View on ClinicalTrials.gov

Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Alopecia
Interventions
DRUG

DNN.22.17.036

Apply twice daily to the affected area and around it.

DRUG

10573048700

Apply twice daily to the affected area and around it.

Sponsors
All Listed Sponsors
lead

Ache Laboratorios Farmaceuticos S.A.

INDUSTRY